Increasing the neurological-disease toolbox using iPSC-derived microglia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. The fusiform gyrus exhibits an epigenetic signature for Alzheimer's disease.Clinical epigenetics · 2020
   Article
2. iPSC modeling of rare pediatric disorders.Journal of neuroscience methods · 2020
   Review
3. Modeling neurological disease using human stem cell-derived microglia-like cells transplanted into rodent brains.Lab animal · 2020
   Article
4. Microglia emerge as central players in brain disease.Nature medicine · 2017
   Review
5. An updated assessment of microglia depletion: current concepts and future directions.Molecular brain · 2017
   Review

Corrections and comments

• Comment on
  Efficient derivation of microglia-like cells from human pluripotent stem cells.2016

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as